ClinicalTrials.govpublic full text
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
breast cancer, dose escalation, phase 1 combination, selective estrogen receptor degrader, hormone sensitive, estrogen receptor, hormone receptor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 883884
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.